Anna Sharman
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility 3
-
- Lung Cancer Diagnosis and Treatment 11
- Lung Cancer Treatments and Mutations 6
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Small Animals top 10%
-
- Global Cancer Incidence and Screening 4
-
- Radiomics and Machine Learning in Medical Imaging 2
-
- Myasthenia Gravis and Thymoma 2
- Co-authors
- David W. DenningIain PageCyprian OpiraMalcolm RichardsonRichard SawyerRosemary ByanyimaHaval BalataRichard Booton
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
Anna Sharman
18 papers receiving 348 citations
Peers
Comparison fields: 5 of 49
- Infectious Diseases 158
- Microbiology 5
- Pulmonary and Respiratory Medicine 191
- Small Animals 35
- Epidemiology 158
Countries citing papers authored by Anna Sharman
This map shows the geographic impact of Anna Sharman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sharman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sharman more than expected).
Fields of papers citing papers by Anna Sharman
This network shows the impact of papers produced by Anna Sharman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sharman. The network helps show where Anna Sharman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Sharman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 11 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 33 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 117 | |
| 12 | 2019 | 15 | |
| 13 | 2019 | 0 | |
| 14 | 2019 | 24 | |
| 15 | 2019 | 17 | |
| 16 | 2018 | 0 | |
| 17 | 2016 | 60 | |
| 18 | 2014 | 0 | |
| 19 | 2009 | 30 | |
| 20 | 2009 | 17 |
About Anna Sharman
Anna Sharman is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine, Oncology, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 353 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Global Cancer Incidence and Screening (4 papers), Antifungal resistance and susceptibility (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Myasthenia Gravis and Thymoma (2 papers). The work is most often cited by research in Infectious Diseases (158 citations), Microbiology (5 citations), Pulmonary and Respiratory Medicine (191 citations), Small Animals (35 citations) and Epidemiology (158 citations). Anna Sharman has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include David W. Denning, Iain Page, Cyprian Opira, Malcolm Richardson, Richard Sawyer, Rosemary Byanyima, Haval Balata, Richard Booton, Philip Crosbie and Eavan G. Muldoon. Their work appears in journals such as Lung Cancer, Thorax, Clinical Radiology, European Radiology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.